High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Oncogene

• Publication date

  2000-08-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1203732PMID 10962557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation

  2000cited by this paper
• Stress‐activated protein kinases are negatively regulated by cell density

  1998cited by this paper
• Fra-1 Induces Morphological Transformation and Increases In Vitro Invasiveness and Motility of Epithelioid Adenocarcinoma Cells

  1998cited by this paper
• Increasing complexity of Ras signaling

  1998cited by this paper
• Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation.

  1998influential reference
• Gene expression profiles in normal and cancer cells.

  1997cited by this paper
• AP-1 function and regulation.

  1997cited by this paper
• Transformation by ras modifies AP1 composition and activity

  1997cited by this paper
• Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts

  1997influential reference
• Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1

  1997cited by this paper
• Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization

  1996cited by this paper
• Cellular transformation and malignancy induced by ras require c-jun

  1996cited by this paper
• c-fos is required for malignant progression of skin tumors.

  1995cited by this paper
• Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*)

  1995cited by this paper
• ATF‐2 is preferentially activated by stress‐activated protein kinases to mediate c‐jun induction in response to genotoxic agents.

  1995cited by this paper
• Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors.

  1995cited by this paper
• Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron

  1995cited by this paper
• Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells

  1995cited by this paper
• JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

  1994cited by this paper
• Analysis of AP-1 function in cellular transformation pathways

  1994cited by this paper
• Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity.

  1994cited by this paper
• Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.

  1994influential reference
• Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.

  1994cited by this paper
• Constitutive ap‐1 dna binding and transactivating ability of malignant but not benign mouse epidermal cells

  1994cited by this paper
• Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases.

  1994cited by this paper
• Ternary complex factors: growth factor regulated transcriptional activators.

  1994cited by this paper
• The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event

  1993cited by this paper
• Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

  1993cited by this paper
• Heterodimer formation of cJun and ATF‐2 is responsible for induction of c‐jun by the 243 amino acid adenovirus E1A protein.

  1993cited by this paper
• Mutation of a phosphorylation site in the DNA-binding domain is required for redox-independent transactivation of AP1-dependent genes by v-Jun.

  1993cited by this paper
• Mammalian G1 cyclins.

  1993cited by this paper
• Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

  1991cited by this paper
• Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain

  1991cited by this paper
• Transformation suppressor activity of a Jun transcription factor lacking its activation domain

  1991cited by this paper
• Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo.

  1991cited by this paper
• Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7.

  1991cited by this paper
• Phosphorylation of c-jun mediated by MAP kinases

  1991cited by this paper
• Isolation and characterization of fra-2, an additional member of the fos gene family.

  1990cited by this paper
• Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7.

  1990cited by this paper
• The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity.

  1989cited by this paper
• jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun.

  1989influential reference
• Characterization of junD: a new member of the jun proto‐oncogene family.

  1989cited by this paper
• Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun.

  1989cited by this paper
• Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene.

  1989influential reference
• Oncogene activation in chemical carcinogenesis.

  1988cited by this paper
• Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene.

  1988cited by this paper
• Chemical carcinogenesis: from animal models to molecular models in one decade.

  1988cited by this paper
• fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen

  1988cited by this paper
• A gene activated by growth factors is related to the oncogene v-jun.

  1988cited by this paper
• Transforming but not immortalizing oncogenes activate the transcription factor PEA1.

  1988cited by this paper
• Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.

  1987cited by this paper
• 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region

  1987cited by this paper
• High-efficiency transformation of mammalian cells by plasmid DNA.

  1987influential reference
• Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis

  1986cited by this paper
• Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells.

  1984cited by this paper
• A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system

  1981cited by this paper
• Harvey and Kirsten sarcoma viruses promote the growth and differentiation of erythroid precursor cells in vitro.

  1981cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Cáncer

  1939cited by this paper

• Progress in the Study of Fra-2 in Respiratory Diseases

  2024cites this paper
• Role of Fra-2 in cancer

  2023cites this paper
• The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases

  2022cites this paper
• Anti-Gastritis and Anti-Lung Injury Effects of Pine Tree Ethanol Extract Targeting Both NF-κB and AP-1 Pathways

  2021cites this paper
• Transcription factor Fra-2 and its emerging role in matrix deposition, proliferation and inflammation in chronic lung diseases.

  2019cites this paper
• The activating transcription factor 2: an influencer of cancer progression

  2019cites this paper
• Modulation of activator protein 1 (AP-1) constituent protein levels by dietary energy restriction (DER) before and after exposure to ultraviolet B (UVB) radiation in SKH-1 mice

  2019cites this paper
• Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights

  2018cites this paper
• Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion

  2018cites this paper
• Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway

  2017cites this paper
• N-bromotaurine surrogates for loss of antiproliferative response and enhances cisplatin efficacy in cancer cells with impaired glucocorticoid receptor.

  2016cites this paper
• Progression of mouse skin carcinogenesis is associated with the orchestrated deregulation of mir‐200 family members, mir‐205 and their common targets

  2016cites this paper
• Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation

  2015cites this paper
• Transcriptional Regulation of Human Osteopontin in Hepatocellular Cacinoma Cells

  2015cites this paper
• MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy

  2015cites this paper
• Metal fume fever among galvanized welders.

  2014cites this paper
• The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.

  2014cites this paper
• THE ROLE OF RASGRP 1 IN RAS-INDUCED HUMAN EPIDERMAL NEOPLASIA A DISSERTATION SUBMITTED TO THE GRADUATE DIVISION OF THE UNIVERSITY OF HAWAI ‘ I AT MĀNOA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY

  2014cites this paper
• The Basic Leucine Zipper Domain Transcription Factor Atf1 Directly Controls Cdc13 Expression and Regulates Mitotic Entry Independently of Wee1 and Cdc25 in Schizosaccharomyces pombe

  2014cites this paper
• The prognostic significance of Jun transcription factors in ovarian cancer

  2013cites this paper
• Role of p38 MAP Kinase Signal Transduction in Solid Tumors.

  2013cites this paper
• The roles of ATF2 (activating transcription factor 2) in tumorigenesis.

  2012cites this paper
• Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma

  2011cites this paper
• Skin Diseases-Related Enzymes: Mechanisms and Clinical Applications

  2011cites this paper
• The Role of Manganese Superoxide Dismutase in Skin Cancer

  2011influential citation
• Etablierung der Chromatin-Immunopräzipitation für in vivo Untersuchungen der Genregulation durch Transkriptionsfaktoren bei der Honigbiene Apis mellifera

  2011cites this paper
• Fos-related antigen 1 (Fra-1) pairing with and transactivation of JunB in GBM cells

  2011cites this paper
• TAF4b and Jun/Activating Protein-1 Collaborate to Regulate the Expression of Integrin α6 and Cancer Cell Migration Properties

  2010cites this paper
• Epigenetic remedies by dietary phytochemicals against inflammatory skin disorders: myth or reality?

  2010cites this paper
• A Dominant-Negative c-jun Mutant Inhibits Lung Carcinogenesis in Mice

  2010cites this paper
• ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP‐1‐dependent manner

  2010cites this paper
• ominant-Negative c-jun Mutant Inhibits Lung Pr R cinogenesis in Mice

  2010cites this paper
• Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-κB oncogenesis

  2010cites this paper
• Emerging roles of ATF2 and the dynamic AP1 network in cancer

  2010cites this paper
• c-Jun-NH2 terminal kinase (JNK)-mediates AP-1 activation by thioredoxin: phosphorylation of cJun, JunB, and Fra-1

  2010cites this paper
• Activation of two distinct MAPK pathways governs constitutive expression of matrix metalloproteinase-1 in human pancreatic cancer cell lines.

  2009cites this paper
• MOLECULAR MECHANISMS FOR REGULATION OF GENE EXPRESSION BY LYSOPHOSPHATIDIC ACID IN OVARIAN CARCINOMA CELLS

  2009cites this paper
• Expression and Significance of FRA-1 in Non-Small-Cell Lung Cancer

  2009cites this paper
• Transcription Factor Fos-Related Antigen-2 Induces Progressive Peripheral Vasculopathy in Mice Closely Resembling Human Systemic Sclerosis

  2009cites this paper
• Transactivation and expression patterns of Jun and Fos/AP‐1 super‐family proteins in human oral cancer

  2009cites this paper
• Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells.

  2008cites this paper
• Regulation of FoxO Transcription Factors in Breast Cancer

  2008cites this paper
• The role of ATF‐2 in oncogenesis

  2008cites this paper
• Fyn is a novel target of (−)‐epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation

  2008cites this paper
• Suppressor role of activating transcription factor 2 (ATF2) in skin cancer

  2008cites this paper
• The functional contrariety of JNK

  2007cites this paper
• Transcription factors control invasion: AP-1 the first among equals

  2007cites this paper
• Analysis of Specific Transcriptional Regulators as Early Predictors of Independent Prognostic Relevance in Resected Colorectal Cancer

  2007cites this paper
• Fra‐1 regulates vimentin during Ha‐RAS‐induced epithelial mesenchymal transition in human colon carcinoma cells

  2007cites this paper
• Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells

  2006cites this paper
• Mycotoxin patulin activates the p38 kinase and JNK signaling pathways in human embryonic kidney cells.

  2006cites this paper
• The p38 transduction pathway in prostatic neoplasia

  2006cites this paper
• Activating transcription factor 2 expression in the adult human brain: association with both neurodegeneration and neurogenesis.

  2005cites this paper
• Fos-Related Antigen 1 Modulates Malignant Features of Glioma Cells

  2005cites this paper
• The sunburn cell: regulation of death and survival of the keratinocyte.

  2005cites this paper
• The Fos family of transcription factors and their role in tumourigenesis.

  2005cites this paper
• Combination Analysis of Activator Protein-1 Family Members, Sp1 and an Activator Protein-2α-Related Factor Binding to Different Regions of the Urokinase Receptor Gene in Resected Colorectal Cancers

  2005cites this paper
• Reduction of Spermatogenesis but Not Fertility in Creb3l4-Deficient Mice

  2005cites this paper
• Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth.

  2005cites this paper
• AP-2 transcription factor family member expression, activity, and regulation in human epidermal keratinocytes in vitro.

  2004cites this paper
• The Role of the AP-1 Transcription Factors c-Fos, FosB, Fra-1 and Fra-2 in the Invasion Process of Mammary Carcinomas

  2004cites this paper
• The p73 gene is an anti-tumoral target of the RARbeta/gamma-selective retinoid tazarotene.

  2004cites this paper
• JNK2: A Negative Regulator of Cellular Proliferation

  2004cites this paper
• Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.

  2004cites this paper
• The p73 gene is an anti-tumoral target of the RARβ/γ-selective retinoid tazarotene

  2004cites this paper
• JNK: A Key Modulator of Intracellular Signaling

  2004cites this paper
• Overexpression of Activating Transcription Factor-2 Is Required for Tumor Growth and Progression in Mouse Skin Tumors

  2004cites this paper
• JNK2 Regulator of Cellular Proliferation

  2004cites this paper
• A Novel Role for Mixed-Lineage Kinase-Like Mitogen-Activated Protein Triple Kinase α in Neoplastic Cell Transformation and Tumor Development

  2004cites this paper
• Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene.

  2004cites this paper
• Expression of Vascular Endothelial Growth Factor ( VEGF )-D and Its Receptor , VEGF Receptor 3 , as a Prognostic Factor in Endometrial Carcinoma 1

  2003cites this paper
• Differential molecular profiling between skin carcinomas reveals four newly reported genes potentially implicated in squamous cell carcinoma development

  2003cites this paper
• Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma

  2003cites this paper
• TAF7 (TAFII55) Plays a Role in the Transcription Activation by c-Jun*

  2003cites this paper
• Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis.

  2003cites this paper
• Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.

  2003cites this paper
• The role of ATF/CREB family members in cell growth, survival and apoptosis

  2003cites this paper
• Biphasic role of TGF-beta1 in signal transduction and crosstalk.

  2003cites this paper
• p38 Mitogen-activated Protein Kinase Regulation of JB6 Cl41 Cell Transformation Promoted by Epidermal Growth Factor*

  2003cites this paper
• Suppression of AP‐1 constitutive activity interferes with polyomavirus MT antigen transformation ability

  2003cites this paper
• Cell proliferation induced by reactive oxygen species is mediated via mitogen-activated protein kinase in Chinese hamster lung fibroblast (V79) cells.

  2003cites this paper
• Biphasic role of TGF‐β1 in signal transduction and crosstalk

  2003cites this paper
• Signal Regulated Gene Expression Mediated by Transcription Factors-Members of AP-1 and ETS/SRF Family Members: Pathways for Potential Therapeutic Intervention

  2003cites this paper
• Gene expression profile in fibroblast growth factor 2-transformed endothelial cells

  2002cites this paper
• The Progression in the Mouse Skin Carcinogenesis Model Correlates With ERK1/2 Signaling

  2002cites this paper
• High Activity of Serum Response Factor in the Mesenchymal Transition of Epithelial Tumor Cells Is Regulated by RhoA Signaling*

  2002cites this paper
• Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors.

  2002cites this paper
• JNK and ERK signaling pathways in multistage mouse carcinogenesis: studies in the inhibition of signaling cascades as a means to understand their in vivo biological role.

  2002cites this paper
• Dominant negative MEKK1 inhibits survival of pancreatic cancer cells

  2002cites this paper
• Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours

  2002cites this paper
• Chapter IX Mapping neuropathology with inducible and constitutive transcription factors

  2002cites this paper
• Role of MAP kinase pathways in primitive neuroectodermal tumors.

  2001cites this paper
• Loss of JunB Activity Enhances Stromelysin 1 Expression in a Model of the Epithelial-to-Mesenchymal Transition of Mouse Skin Tumors

  2001cites this paper
• Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis

  2001cites this paper
• VEGF-D is an X-linked/AP-1 Regulated Putative Onco-angiogen in Human Glioblastoma Multiforme

  2001cites this paper
• Role of matrix metalloproteinase‐9 in progression of mouse skin carcinogenesis

  2001cites this paper
• Jun, the oncoprotein

  2001influential citation
• AP-1 Transcription Factors and Steroid Hormone Re­ ceptors in Multistage Mouse Skin Carcinogenesis

  2001cites this paper
• Inhibitory effect of glycolic acid on ultraviolet‐induced skin tumorigenesis in SKH‐1 hairless mice and its mechanism of action

  2001cites this paper
• Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model.

  2001cites this paper